141 related articles for article (PubMed ID: 9145417)
21. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of calcium concentration on mu and kappa agonist actions in the guinea pig ileum.
Johnson MA; Hill RG; Hughes J
NIDA Res Monogr; 1986; 75():69-72. PubMed ID: 2829010
[TBL] [Abstract][Full Text] [Related]
23. Functional activities of synthetic anaphylatoxic peptides in widely used biological assays.
Kola A; Klos A; Bautsch W; Kretzschmar T; Köhl J
Clin Exp Immunol; 1992 May; 88(2):368-72. PubMed ID: 1572104
[TBL] [Abstract][Full Text] [Related]
24. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
[TBL] [Abstract][Full Text] [Related]
25. Anaphylactic actions of platelet-activating factor.
Stimler NP; Bloor CM; Hugli TE; Wykle RL; McCall CE; O'Flaherty JT
Am J Pathol; 1981 Oct; 105(1):64-9. PubMed ID: 6975043
[TBL] [Abstract][Full Text] [Related]
26. Selective opioid dipeptides.
Temussi PA; Salvadori S; Amodeo P; Bianchi C; Guerrini R; Tomatis R; Lazarus LH; Picone D; Tancredi T
Biochem Biophys Res Commun; 1994 Feb; 198(3):933-9. PubMed ID: 8117299
[TBL] [Abstract][Full Text] [Related]
27. Distinct classes of substance P receptors revealed by a comparison of the activities of substance P and some of its segments.
Teichberg VI; Cohen S; Blumberg S
Regul Pept; 1981 Feb; 1(5):327-33. PubMed ID: 6166965
[TBL] [Abstract][Full Text] [Related]
28. Effects of 'casoparan', a peptide isolated from casein hydrolysates with mastoparan-like properties.
Lebrun I; Cavallaro V; Juliano L; Juliano MA; de Sousa e Silva MC
Mediators Inflamm; 2004 Aug; 13(4):263-8. PubMed ID: 15545057
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides.
Tomatis R; Marastoni M; Balboni G; Guerrini R; Capasso A; Sorrentino L; Santagada V; Caliendo G; Lazarus LH; Salvadori S
J Med Chem; 1997 Aug; 40(18):2948-52. PubMed ID: 9288177
[TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of a new bradykinin potentiating octapeptide from gamma-casein.
Lebrun I; Lebrun FL; Henriques OB; Carmona AK; Juliano L; Camargo AC
Can J Physiol Pharmacol; 1995 Jan; 73(1):85-91. PubMed ID: 7600458
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin, and alpha S1-casomorphin amide).
Kampa M; Loukas S; Hatzoglou A; Martin P; Martin PM; Castanas E
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):903-8. PubMed ID: 8920997
[TBL] [Abstract][Full Text] [Related]
32. Activation and internalization of the mu-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2.
McConalogue K; Grady EF; Minnis J; Balestra B; Tonini M; Brecha NC; Bunnett NW; Sternini C
Neuroscience; 1999 Mar; 90(3):1051-9. PubMed ID: 10218804
[TBL] [Abstract][Full Text] [Related]
33. The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone.
Beattie DT; Cheruvu M; Mai N; O'Keefe M; Johnson-Rabidoux S; Peterson C; Kaufman E; Vickery R
Naunyn Schmiedebergs Arch Pharmacol; 2007 May; 375(3):205-20. PubMed ID: 17340127
[TBL] [Abstract][Full Text] [Related]
34. Relationship between inhibitory effect of endogenous opioid via mu-receptors and muscarinic autoinhibition in acetylcholine release from myenteric plexus of guinea pig ileum.
Nishiwaki H; Saitoh N; Nishio H; Takeuchi T; Hata F
Jpn J Pharmacol; 1998 Aug; 77(4):279-86. PubMed ID: 9749928
[TBL] [Abstract][Full Text] [Related]
35. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
36. N-acylated pentapeptides antagonists of substance P on guinea-pig ileum.
Schmitt P; Mayer M; Magneney S; Michelot R; Potier P
Biochem Biophys Res Commun; 1988 Oct; 156(1):323-7. PubMed ID: 2460099
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands.
Rew Y; Malkmus S; Svensson C; Yaksh TL; Chung NN; Schiller PW; Cassel JA; DeHaven RN; Taulane JP; Goodman M
J Med Chem; 2002 Aug; 45(17):3746-54. PubMed ID: 12166947
[TBL] [Abstract][Full Text] [Related]
38. Potent morphiceptin analogs: structure activity relationships and morphine-like activities.
Chang KJ; Wei ET; Killian A; Chang JK
J Pharmacol Exp Ther; 1983 Nov; 227(2):403-8. PubMed ID: 6313901
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the structural parameters involved in the mu and delta opioid receptor discrimination of linear enkephalin-related peptides.
Gacel G; Zajac JM; Delay-Goyet P; Daugé V; Roques BP
J Med Chem; 1988 Feb; 31(2):374-83. PubMed ID: 2828622
[TBL] [Abstract][Full Text] [Related]
40. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
